Structure and Functional Status of Parotid Glands Exposed to Therapeutic Irradiation
NCT00001523 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2008-03-04
Summary
Therapeutic irradiation to the head and neck for cancer damages salivary glands present in the radiation field. Despite long recognition of radiation-induced salivary hypofunction, and the associated oral morbidities, the specific damage mechanism(s) is not known and the structure and functional integrity of the surviving parenchymal tissue has not been well-documented. Detailed knowledge of the latter is particularly necessary in order to design appropriate corrective therapies. It is the purpose of this study to provide such a detailed structural and functional assessment of human parotid glands following irradiation. The study will examine 20 patients beginning just prior to therapeutic irradiation and continuing at intervals for 3 years for a total of 5 study visits. Study visits (prior to irradiation and at 4 weeks, 12 weeks, 12 months and 36 months post-irradiation) will include the following procedures: i) detailed oral exam and structured interview; ii) salivary gland functional assessment; iii) sialography of each parotid gland; iv) 99mTcO4 scan of the salivary glands; and v) a magnetic resonance imaging (MRI) scan of the parotid glands. Based on previous single observation studies in humans, and more detailed animal studies, we hypothesize that ionizing radiation will lead to reduced parotid gland function and diminished salivary parenchymal tissue (with a preferential loss in acinar versus ductal cells). Further, we hypothesize that the parenchymal loss will increase with time (replaced by fat and connective tissue) and lead to progressive irreversible salivary dysfunction.
Conditions
- Radiation Injuries
- Xerostomia
Sponsors & Collaborators
-
National Institute of Dental and Craniofacial Research (NIDCR)
lead NIH
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1996-05-31
- Completion
- 2000-03-31
Countries
- United States
Study Locations
More Related Trials
-
Oropharyngeal Function After Radiotherapy With IMRT
NCT00506324 ·Status: TERMINATED
-
Evaluation of Treatment Related Toxicity After Radiotherapy for Head and Neck Cancer
NCT01621048 ·Status: WITHDRAWN
-
Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation Therapy
NCT00928161 ·Status: WITHDRAWN ·Phase: NA
-
Functional Sparing of Salivary Glands Using MRI Sialography for Patients Undergoing Definitive Radiation Therapy for Head and Neck Cancers of the Oropharynx
NCT03418792 ·Status: COMPLETED ·Phase: NA
-
Can Cytokines Predict the Severity of Acute Mucositis and the Need for Gastrostomy Tubes (PEG)?
NCT00431925 ·Status: UNKNOWN
-
Cross-Sectional Study of Oral Health in Patients After Parotid-Sparing Radiation Therapy for Head and Neck Cancer
NCT01663246 ·Status: COMPLETED ·Phase: NA
-
Prospective Study on Monitoring Parotid Gland Injury After Radiotherapy for Head and Neck Tumors Using Multimodal Radiomics
NCT06792526 ·Status: NOT_YET_RECRUITING
-
Sparing Parotid Ducts Via MRI Sialography for Reduced Patient-Reported Xerostomia
NCT07278557 ·Status: RECRUITING ·Phase: PHASE2
-
Parotid-Sparing Intensity-Modulated Radiation Therapy Compared With Conventional Radiation Therapy in Treating Patients With Oropharyngeal or Hypopharyngeal Cancer Who Are at High Risk of Radiation-Induced Xerostomia
NCT00081029 ·Status: UNKNOWN ·Phase: PHASE3
-
Prospective Studies on Oral Health and Quality of Life in Head and Neck Cancer Patients
NCT02870270 ·Status: COMPLETED
-
The Effectiveness of a Thyme and Honey Spray for Oral Toxicities
NCT04880148 ·Status: UNKNOWN ·Phase: NA
-
Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth
NCT03874572 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Saliva, Hyperbaric Oxygen Therapy, & Gland Function: A Prospective Study
NCT01532479 ·Status: WITHDRAWN
-
Prospective Evaluation of Patient Reported Xerostomia After Whole Brain Radiation
NCT02682199 ·Status: COMPLETED
-
Treatment Outcomes and Quality of Life After IMRT Treatments of Head and Neck Cancers
NCT00230256 ·Status: COMPLETED
-
Intraoral Hypothermia Device for Preserving Taste During Radiation
NCT06579248 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Study Using Intensity-modulated Radiation Therapy in Patients With Nasopharynx Cancer to Permit Sparing of Contralateral Parotid Gland Function
NCT00123864 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Trial Comparing Oral Pilocarpine (Salagen) Versus Submandibular Salivary Gland Transfer Protocol, For the Prevention of Radiation (XRT) Induced Xerostomia in Head and Neck Cancer Patients
NCT00168181 ·Status: COMPLETED ·Phase: PHASE3
-
Electroacupuncture in Treating Chronic Dry Mouth Caused By Radiation Therapy in Patients With Head and Neck Cancer
NCT00623129 ·Status: TERMINATED ·Phase: NA
-
Xerostomia in Head and Neck Cancer Patients Receiving Radiation as the Primary Treatment Versus Patients Who Will Not Have Such a Procedure
NCT00168116 ·Status: COMPLETED ·Phase: PHASE2
-
Stromal Vascular Fraction for Treatment of Xerostomia
NCT03061110 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Effectiveness of Photobiomodulation Protocols in Radiation-induced Oral Side Effects in H&N Cancer Patients
NCT05242991 ·Status: UNKNOWN ·Phase: NA
-
Repeated Mesenchymal Stem Cell Therapy for Radiation-Induced Hyposalivation and Xerostomia in Head and Neck Cancer Survivors
NCT07290946 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Prevalence of Late Xerostomia and Hyposalivation with Associated Risk Factors in Survivors of Head and Neck Cancer After Radiotherapy: a Multi-centric Cross-sectional Study
NCT06851572 ·Status: COMPLETED
-
Hyperbaric Oxygen - a New Treatment Modality in Patients With Radiation Damaged Salivary Gland Tissue
NCT01606644 ·Status: UNKNOWN ·Phase: PHASE3